Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917306 · ClinicalTrials.gov registry record · Phase 3
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
A Phase 3 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 3
- Development phase
- 102
- Enrollment target
NCT00917306 is a Phase 3 study that has completed, run by Peplin. The registered enrollment target is 102 participants.
The verdict
NCT00917306, a Phase 3 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 102 participants
- Enrollment target
Study Summary
The open label study is designed to assess the safety and efficacy of 0.05% PEP005 Gel when applied to an area of skin containing 4-8 AK lesions on non-head locations.
Interventions
- DRUG PEP005 Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00917306
The ClinicalTrials.gov registry entry for NCT00917306 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PEP005 Gel is the first listed.
NCT00917306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00917306 about?
NCT00917306 is a clinical study titled "A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)". The open label study is designed to assess the safety and efficacy of 0.05% PEP005 Gel when applied to an area of skin containing 4-8 AK lesions on non-head locations.
What is the current status of trial NCT00917306?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 102 participants. The study started on 2009-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00917306?
The interventions under investigation include: PEP005 Gel (DRUG).
Who is sponsoring clinical trial NCT00917306?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.